MAYO CLINIC

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Established: 1889-01-01

Employees: 10K

Market Cap: -

Website: http://www.mayoclinic.org

Clinical Trials

A Study of Contralateral Limb Block

Phase 4

Recruiting

Conditions: Limb Pain, Phantom

Interventions: Drug: Placebo
Drug: Lidocaine

First Posted Date: 2023-09-21

Last Posted Date: 2024-06-25

Lead Sponsor: Mayo Clinic

Target Recruit Count: 20

Registration Number: NCT06045936

Locations: 🇺🇸
Mayo Clinic Health System - Mankato, Mankato, Minnesota, United States

Optimal Stent Duration After Ureteroscopy

Not Applicable

Conditions: Ureteral Stent

Interventions: Device: Ureteral stent

First Posted Date: 2023-09-21

Last Posted Date: 2024-10-10

Lead Sponsor: Mayo Clinic

Target Recruit Count: 172

Registration Number: NCT06045962

Locations: 🇺🇸
Johns Hopkins University, Baltimore, Maryland, United States
🇺🇸
University of Arizona, Tucson, Arizona, United States
🇺🇸
Mayo Clinic Arizona, Phoenix, Arizona, United States

and more 8 locations

MC210808 Venetoclax in Combination With Lenalidomide and Dexamethasone (Ven-Rd), Daratumumab and Dexamethasone (Ven-Dd), or Daratumumab-Lenalidomide-Dexamethasone (Ven-DRd) for the Treatment of Multiple Myeloma

Phase 1

Recruiting

Conditions: Multiple Myeloma

Interventions: Procedure: Biospecimen Collection
Procedure: Bone Marrow Aspiration
Procedure: Bone Marrow Biopsy
Procedure: Chest Radiography
Procedure: Computed Tomography
Biological: Daratumumab
Drug: Dexamethasone
Drug: Lenalidomide
Procedure: Low Dose Computed Tomography of the Whole Body
Procedure: Magnetic Resonance Imaging
Procedure: Positron Emission Tomography
Drug: Venetoclax
Procedure: X-Ray Imaging
Other: Questionnaire Administration

First Posted Date: 2023-09-18

Last Posted Date: 2024-12-02

Lead Sponsor: Mayo Clinic

Target Recruit Count: 100

Registration Number: NCT06042725

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

Effect of Vagal Nerve Stimulation on Gastric Motor Functions

Not Applicable

Recruiting

Conditions: Depression
Epilepsy

Interventions: Device: Vagal nerve stimulant

First Posted Date: 2023-09-15

Last Posted Date: 2024-12-11

Lead Sponsor: Mayo Clinic

Target Recruit Count: 16

Registration Number: NCT06038929

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
🇺🇸
University of Minnesota, Minneapolis, Minnesota, United States

Evaluation of the Impact of Empty Versus Full Bladder in Patients with Prostate Cancer, RELIEF Trial

Not Applicable

Recruiting

Conditions: Prostate Carcinoma

Interventions: Procedure: Computed Tomography
Other: Best Practice
Other: Electronic Health Record Review
Procedure: Imaging Technique
Other: Questionnaire Administration
Radiation: Radiation Therapy

First Posted Date: 2023-09-14

Last Posted Date: 2024-12-09

Lead Sponsor: Mayo Clinic

Target Recruit Count: 168

Registration Number: NCT06037863

Locations: 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States
🇺🇸
Mayo Clinic Health System in Albert Lea, Albert Lea, Minnesota, United States

and more 4 locations

CARE: Cancer Risk Perception and Women of Color

Recruiting

Conditions: Breast Carcinoma

Interventions: Other: Non-Interventional Study

First Posted Date: 2023-09-14

Last Posted Date: 2024-10-24

Lead Sponsor: Mayo Clinic

Target Recruit Count: 550

Registration Number: NCT06036875

Locations: 🇺🇸
University of Arizona, Tucson, Arizona, United States
🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States

A Study of Ultra High Dose Diuretics to Treat Heart Failure

Phase 2

Completed

Conditions: Heart Failure; With Decompensation

Interventions: Drug: Furosemide
Drug: Bumetanide

First Posted Date: 2023-09-14

Last Posted Date: 2024-12-19

Lead Sponsor: Mayo Clinic

Target Recruit Count: 20

Registration Number: NCT06036914

Locations: 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States

A Study of Perturbation of Human Small Intestinal Colonic Permeability

Early Phase 1

Recruiting

Conditions: Healthy

Interventions: Dietary Supplement: Ricinoleic Acid 1500 mg
Drug: Placebo
Dietary Supplement: Ricinoleic Acid 750 mg
Dietary Supplement: Ricinoleic Acid 3000 mg

First Posted Date: 2023-09-13

Last Posted Date: 2024-06-12

Lead Sponsor: Mayo Clinic

Target Recruit Count: 24

Registration Number: NCT06033222

Locations: 🇺🇸
Mayo Clinic Minnesota, Rochester, Minnesota, United States

Virtual Mindfulness and Weight Management to Mitigate Risk of Relapse and Improve Wellbeing in Cancer Survivors

Not Applicable

Completed

Conditions: Malignant Solid Neoplasm
Obesity-Related Malignant Neoplasm
Hematopoietic and Lymphoid System Neoplasm

Interventions: Behavioral: Behavioral Dietary Intervention
Other: Educational Intervention
Other: Health Promotion and Education
Other: Internet-Based Intervention
Other: Interview
Other: Medical Device Usage and Evaluation
Behavioral: Mindfulness Relaxation
Other: Physical Performance Testing
Other: Questionnaire Administration

First Posted Date: 2023-09-11

Last Posted Date: 2024-12-02

Lead Sponsor: Mayo Clinic

Target Recruit Count: 19

Registration Number: NCT06030427

Locations: 🇺🇸
Mayo Clinic Health System-Franciscan Healthcare, La Crosse, Wisconsin, United States

Dual Implant Versus Single Implant Distal End of Femur

Not Applicable

Recruiting

Conditions: Femur Fracture

Interventions: Procedure: Single Distal Femur Implant
Procedure: Dual Distal Femur Implant

First Posted Date: 2023-09-11

Last Posted Date: 2024-06-05

Lead Sponsor: Mayo Clinic

Target Recruit Count: 60

Registration Number: NCT06032299

Locations: 🇺🇸
Mayo Clinic Minnesota, Rochester, Minnesota, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy